Elkington And Fife patent opposition analysis

The comprehensive analysis of Elkington And Fife opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Elkington And Fife

Patent NumberTitleApplicantOpposition DateOpposition Company
Absorbent Article Comprising Elastomeric StripsHAYAT KIMYA SAN. A.S.Sep 4, 2026THE PROCTER & GAMBLE
Pharmaceutical Formulations Containing Relacorilant, A Heteroaryl-Ketone Fused Azadecalin CompoundCORCEPT THERAPEUTICS INCORPORATEDSep 2, 2026ELKINGTON AND FIFE
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIM INTERNATIONAL GMBHSep 2, 2026POLPHARMA
Sglt-2 Inhibitor For Treating Type 1 Diabetes Mellitus, Type 2 Diabete Mellitus, Impaired Glucose Tolerance Or HyperglycemiaBOEHRINGER INGELHEIM INTERNATIONAL GMBHAug 26, 2026ELKINGTON AND FIFE
Sglt-2 Inhibitor For Treating Type 1 Diabetes Mellitus, Type 2 Diabete Mellitus, Impaired Glucose Tolerance Or HyperglycemiaBOEHRINGER INGELHEIM INTERNATIONAL GMBHAug 25, 2026SANDOZ
Absorbent Article With Anti-Leakage Transversal BarrierONTEX BVAug 19, 2026THE PROCTER & GAMBLE
Aqueous Formulation Comprising 1-(4-{[4-(Dimethylamino)Piperidin-1-Yl]Carbonyl}Phenyl)-3-[4-(4,6-Dimorpholin-4-Yl-1,3,5-Triazin-2-Yl)Phenyl]UreaPFIZER INC.Aug 16, 2026ELKINGTON AND FIFE
Ribociclib TabletNOVARTIS AGAug 11, 2026GENERICS UK
Crystalline Form Of (S)-7-(1-Acryloylpiperidin-4-Yl)-2-(4-Phenoxyphenyl)-4,5,6,7-Tetra-Hydropyrazolo[1,5-A]Pyrimidine-3-Carboxamide, Preparation, And Uses ThereofBEONE MEDICINES I GMBHAug 3, 2026SANDOZ
Compositions And Methods For Treating Disorders Ameliorated By Muscarnic Receptor ActivationKARUNA THERAPEUTICS, INC.Jul 30, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD